Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Not applicable

Screen Use by Children in a Pediatric Waiting Room and the Effect of an Environmental Intervention

NCT07933926 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2026-10-01
Last updated
2026-11-12

Condition(s) studied

Screen Time

Investigational drug(s) / intervention(s)

Environmental waiting room intervention

Environmental waiting room intervention: Modification of the physical environment of the pediatric waiting room to reduce screen use: posters for parents and caregivers on the benefits of reducing screen exposure; play and educational materials (books, puzzles, board games, and educational toys); and boards or murals for children and adults to draw or write on.

Study summary

The goal of this clinical trial is to learn if changing the physical environment of a pediatric waiting room can reduce the use of screen devices (such as mobile phones and tablets) by children aged 2 to 8 years while they wait for their appointment. The main questions it aims to answer are:

* Does the proportion of children who use a screen device in the waiting room decrease after the intervention?
* What types of digital content do children use most often in the waiting room, and which sociodemographic factors are associated with screen use? Researchers will compare children seen before the waiting room was changed with children seen after the change to see if fewer children use screen devices.

The intervention consists of posters for parents and caregivers on the benefits of reducing screen time, play and educational materials (books, puzzles, board games, and educational toys), and boards or murals where children and adults can draw or write.

Parents or legal guardians of participating children will complete a short anonymous survey on a tablet in the waiting room.

Eligibility

Sex
ALL
Min age
2 Years
Max age
8 Years
Healthy volunteers
No
Inclusion Criteria: * Children aged 2 to 8 years attended at the Pediatrics Service of CAPI Baix a Mar (CSAPG) * Waiting time of at least 5 minutes in the waiting room before the consultation Exclusion Criteria: * Severe visual or hearing impairment that limits usual interaction with screen devices * Diagnosis of a severe neurodevelopmental disorder, according to the investigator's judgment (for example, severe autism spectrum disorder) * Parent or legal guardian unable to complete the survey because of a language barrier or other limitations

Primary outcome measure(s)

  • Proportion of children using a screen device in the waiting room — Baseline
    Proportion of children who use any screen device (mobile phone, tablet, game console, or similar) in the waiting room before the consultation, reported by the parent or legal guardian in the study survey. Screen use is defined as the child actively watching or handling a screen device.

Trial sites (1)

FacilityCityRegionStatus
CAPI Baix a Mar (CSAPG) Vilanova i la Geltrú Barcelona Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07933926 on ClinicalTrials.gov ↗ ← All trials in Spain